BMC Nephrology is affiliated with the UK Kidney Association
Influence of safety warnings on ESA prescribing among dialysis patients using an interrupted time series
In March, 2007, a black box warning was issued by the Food and Drug Administration (FDA) to use the lowest possible erythropoiesis-stimulating agents (ESA) doses for treatment of anemia associated with renal d...